CD133, Trop-2 and alpha2beta1 integrin surface receptors as markers of putative human prostate cancer stem cells.
Cancer stem cells (CSCs) play a key role in initiation and development of cancer and are attractive targets for therapy. The identification of CSC surface receptors to be used as therapeutic targets in vivo remains a difficult task. In this study, we assessed the expression pattern of three surface receptors: CD133, Trop-2 and alpha2beta1 integrin in human prostate cancer in order to identify CSC-niches. CD133 was found to be expressed in small clusters of cells localized in focal areas of benign as well as malignant lesions, suggesting that this protein is a bona fide marker of the prostate stem/progenitor compartment. Trop-2 was localized in both basal and luminal layers of benign glands and was highly expressed in malignant lesions. Moreover, isolated cells in benign and malignant areas were found to co-express both CD133 and Trop-2. alpha2beta1 integrin was expressed in the prostatic epithelium as well as in the surrounding stroma, limiting its utility as a marker of CSCs. In summary, we demonstrate that the combination of CD133 and Trop-2 is useful to mark putative CSC-containing compartments in human prostate.
Trerotola
Marco
M
Rathore
Swati
S
Goel
Hira Lal
HL
Li
Jing
J
Alberti
Saverio
S
Piantelli
Mauro
M
Adams
Dave
D
Jiang
Zhong
Z
Languino
Lucia R
LR
Eur J Cancer. 2007 Mar;43(5):935-46
17320377
Curr Mol Med. 2008 Dec;8(8):784-804
19075676
Cancer Sci. 2009 Jun;100(6):1040-6
19385971
Biochem Biophys Res Commun. 2009 Feb 20;379(4):1091-6
19159617
Mod Pathol. 2002 Dec;15(12):1302-8
12481011
Proc Natl Acad Sci U S A. 1981 Aug;78(8):5147-50
7029529
Nature. 2006 Dec 7;444(7120):756-60
17051156
Cancer Cell. 2004 Aug;6(2):159-70
15324699
J Cell Sci. 2006 Apr 1;119(Pt 7):1416-24
16554439
J Pathol. 2009 Jan;217(2):299-306
19040209
Prostate. 1998 Nov 1;37(3):149-60
9792132
Prostate Suppl. 1989;2:33-50
2482772
Prostate. 2009 May 15;69(7):787-98
19189306
Stem Cells. 2009 Dec;27(12):2875-83
19816957
Am J Transl Res. 2009 Apr 20;1(3):211-20
19956432
Stem Cell Rev. 2008 Dec;4(4):319-28
18561035
Curr Opin Cell Biol. 2009 Oct;21(5):623-9
19535237
Nature. 2006 Jun 29;441(7097):1075-9
16810242
Int J Cancer. 1995 Jan 3;60(1):88-92
7814156
Nature. 2004 Nov 18;432(7015):396-401
15549107
Cancer Res. 2010 Jan 15;70(2):719-29
20068153
Histol Histopathol. 2007 Sep;22(9):1043-9
17523082
Biochem Biophys Res Commun. 2006 Dec 29;351(4):820-4
17097610
J Cell Sci. 2004 Jul 15;117(Pt 16):3539-45
15226377
Cancer Res. 2005 Dec 1;65(23):10946-51
16322242
Prostate. 2008 Jun 15;68(9):1007-24
18398820
Nat Cell Biol. 2008 Jun;10(6):716-22
18469806
J Proteome Res. 2009 Feb;8(2):620-30
19128049
Clin Cancer Res. 2006 May 15;12(10):3057-63
16707602
Am J Pathol. 1998 Sep;153(3):911-9
9736039
Glycobiology. 2003 Jun;13(6):457-70
12626390
J Clin Invest. 2008 Jun;118(6):2021-4
18497883
J Clin Oncol. 2008 Jun 10;26(17):2862-70
18539965
J Clin Invest. 1999 Feb;103(3):321-9
9927492
Blood. 1997 Dec 15;90(12):5002-12
9389720
Cancer Res. 2007 Apr 1;67(7):3153-61
17409422
Clin Exp Metastasis. 2009;26(5):433-46
19221883
Exp Cell Res. 2008 Oct 1;314(16):2941-50
18703050
J Proteome Res. 2007 Sep;6(9):3475-83
17705522
Cancer Res. 2005 Jul 15;65(14):6466-75
16024652
Prostate. 2009 Apr 1;69(5):559-69
19142959
Cancer. 2007 Jul 15;110(2):452-64
17559145
Nat Neurosci. 2005 Jun;8(6):723-9
15908947
Cancer Res. 2002 Dec 1;62(23):6837-45
12460896
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20882-7
19088204
Cancer Res. 2006 Oct 1;66(19):9339-44
16990346
J Cell Sci. 2001 Nov;114(Pt 21):3865-72
11719553
Endocr Relat Cancer. 2008 Sep;15(3):657-64
18524948
Endocr Rev. 2008 Apr;29(2):234-52
18292464
Nat Rev Cancer. 2008 Jul;8(7):545-54
18511937
Nature. 2001 Nov 1;414(6859):105-11
11689955
Nat Genet. 2008 May;40(5):499-507
18443585
J Urol. 1998 Dec;160(6 Pt 2):2381-92
9817389
Clin Chim Acta. 2009 May;403(1-2):17-22
19118539
Int J Clin Exp Pathol. 2009;2(4):361-9
19158933
Nature. 2007 Jan 4;445(7123):106-10
17122772
J Clin Invest. 2008 Jun;118(6):2111-20
18497886
Am J Transl Res. 2009 Jan 01;1(1):80-6
19966941
Br J Cancer. 2008 Oct 21;99(8):1290-5
18813308
Stem Cell Rev. 2008 Sep;4(3):193-201
18563640
J Mol Med (Berl). 2008 Sep;86(9):1025-32
18535813
Annu Rev Cell Dev Biol. 2007;23:675-99
17645413